Impacts of Matrix Metalloproteinase-11 Genotypes on Pterygium Risk

Ning-Yi Hsia1, Hung-Chih Chen2,3, Hung-Wen Tsai4

  • 1Department of Ophthalmology, China Medical University Hospital, Taichung, Taiwan, R.O.C.

Anticancer Research
|October 30, 2024
PubMed
Abstract

Insights

Matrix metalloproteinase-11 (MMP-11) gene variants, specifically rs738792, are associated with pterygium risk in Taiwanese populations. These MMP-11 genotypes may serve as predictive markers for pterygium development.

Area of Science:

  • Genetics
  • Ophthalmology
  • Molecular Biology

Background:

  • Matrix metalloproteinase (MMP) dysregulation is implicated in pterygium.
  • The specific role of matrix metalloproteinase-11 (MMP-11) in pterygium pathogenesis remains understudied.

Purpose of the Study:

  • This research investigates the genomic association of matrix metalloproteinase-11 (MMP-11) single nucleotide polymorphisms (SNPs) with pterygium.
  • To determine if MMP-11 gene variants are risk factors for pterygium development.

Main Methods:

  • Genotyping of four MMP-11 SNPs (rs738791, rs2267029, rs738792, rs28382575) was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and direct sequencing.
  • A case-control study design included 140 pterygium cases and 280 non-pterygium controls.

Main Results:

  • The genotypic frequencies of MMP-11 rs738792 showed a significant association with pterygium risk (p for trend=0.0139).
  • Carriers of the CT and CC genotypes for rs738792 had an increased odds ratio for pterygium risk.
  • Allelic analysis revealed that the C allele of MMP-11 rs738792 was significantly associated with higher pterygium risk (OR=1.48, 95%CI=1.08-2.01, p=0.0169).

Conclusions:

  • MMP-11 rs738792 genotypes can function as a predictive biomarker for pterygium risk in the Taiwanese population.
  • Understanding MMP-11's role in pterygium pathogenesis may lead to targeted therapeutic strategies.